Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

Rahul Aggarwal, Jiaoti Huang, Joshi J. Alumkal, +28

Journal of Clinical Oncology

T-scnc DetectionUrologyGenitourinary CancerMedicinePathology +9

Genomic Drivers of Poor Prognosis and Enzalutamide Resistance in Metastatic Castration-resistant Prostate Cancer

William S. Chen, Rahul Aggarwal, Li Zhang, +25

European Urology

UrologyEnzalutamide ResistanceGenitourinary CancerTumor HeterogeneityMedicine +8

EVEREST: Everolimus for renal cancer ensuing surgical therapy—A phase III study (SWOG S0931, NCT01120249).

Christopher W. Ryan, Catherine M. Tangen, Elisabeth I. Heath, +17

Journal of Clinical Oncology

Surgical OncologyRenal PathologySurgeryOncologyGenitourinary Cancer +14

Phase II study of eribulin (E7389) in patients (pts) with advanced urothelial cancer (UC)—Final report: A California Cancer Consortium-led NCI/CTEP-sponsored trial.

David I. Quinn, Ana M. Aparicio, Denice Tsao‐Wei, +7

Journal of Clinical Oncology

Renal PathologyRenal InflammationPhase Ii StudyPharmacotherapy—Final Report +21

Activity of high-dose toremifene plus cisplatin in platinum-treated non-small-cell lung cancer: a phase II California Cancer Consortium Trial

Primo Lara, David R. Gandara, Jeff Longmate, +11

Cancer Chemotherapy and Pharmacology

OncologyHigh-dose ToremifenePharmacologyPharmacotherapyAnti-cancer Agent +4

Results of a Phase II Placebo-controlled Randomized Discontinuation Trial of Cabozantinib in Patients with Non–small-cell Lung Carcinoma

Beth A. Hellerstedt, Nicholas J. Vogelzang, Harriet M. Kluger, +5

Clinical Lung Cancer

Implications of lymph node retrieval in locoregional rectal cancer treated with chemoradiotherapy: A California Cancer Registry Study

Amandeep Gill, Ann Brunson, Primo Lara, +2

European Journal of Surgical Oncology

Surgical OncologyRadiation TherapyLymph Node RetrievalMedicineCancer Recurrence +9

Oblimersen and α-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium

Kim Margolin, Timothy W. Synold, Primo Lara, +8

Journal of Cancer Research and Clinical Oncology

UrologyCalifornia Cancer ConsortiumMetastatic Renal CancerGenitourinary CancerKidney Research +5

Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer

Elisabeth I. Heath, Lance K. Heilbrun, Heather D. Mannuel, +15

The Oncologist

PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with localized renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143).

Lauren C. Harshman, Mäneka Puligandla, Naomi B. Haas, +17

Journal of Clinical Oncology

Surgical OncologyImmunologyImmunoeditingSurgeryImmunotherapeutics +21